Exact Mass: 568.3043

Exact Mass Matches: 568.3043

Found 71 metabolites which its exact mass value is equals to given mass value 568.3043, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Protoporphyrinogen IX

3-[20-(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid

C34H40N4O4 (568.3049)


Protoporphyrinogen IX is an intermediate in heme biosynthesis. It is a porphyrinogen in which two pyrrole rings each have one methyl and one propionate side chain, and the other two pyrrole rings each have one methyl and one vinyl side chain. Fifteen isomers are possible but only one, type IX, occurs naturally. Protoporphyrinogen is produced by oxidative decarboxylation of coproporphyrinogen. Under certain conditions, protoporphyrinogen IX can act as a phototoxin, a neurotoxin, and a metabotoxin. A phototoxin leads to cell damage upon exposure to light. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, and hereditary coproporphyria (HCP). In particular, protoporphyrinogen IX is accumulated and excreted excessively in the feces in acute intermittent porphyria, protoporphyria, and variegate porphyria. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503). Protoporphyrinogen IX is an intermediate in heme biosynthesis. It is a porphyrinogen in which 2 pyrrole rings each have one methyl and one propionate side chain and the other two pyrrole rings each have one methyl and one vinyl side chain. 15 isomers are possible but only one, type IX, occurs naturally. Protoporphyrinogen is produced by oxidative decarboxylation of coproporphyrinogen. [HMDB]. Protoporphyrinogen IX is found in many foods, some of which are elderberry, grapefruit, green vegetables, and pepper (c. annuum). COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Adouetine Y

N-[(10Z)-7-(Butan-2-yl)-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidate

C34H40N4O4 (568.3049)


Adouetine Y is found in tea. Adouetine Y is an alkaloid from the root bark of Ceanothus americanus (New Jersey tea). Alkaloid from the root bark of Ceanothus americanus (New Jersey tea). Adouetine Y is found in tea.

   
   

5-Oxoavermectin 1b aglycone

5-Oxoavermectin 1b aglycone

C33H44O8 (568.3036)


   

Ceanothine E

(Z)-N-[(5E,8E,10Z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropimidic acid

C34H40N4O4 (568.3049)


Ceanothine E is found in tea. Ceanothine E is an alkaloid from the root bark of Ceanothus americanus (New Jersey tea

   

3-[18-(2-Carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethyl-21,22,23,24-tetrahydroporphyrin-2-yl]propanoic acid

3-[20-(2-carboxyethyl)-10,15-diethyl-5,9,14,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),2,4,6,8,10,12,14,16,18-decaen-4-yl]propanoic acid

C34H40N4O4 (568.3049)


   

Fumigacin

Helvolic acid

C33H44O8 (568.3036)


   
   

Preamentol triacetate

(+)-Preamentol triacetate

C33H44O8 (568.3036)


   
   
   

Sarothralen A|Sarothralin A

Sarothralen A|Sarothralin A

C33H44O8 (568.3036)


   

amentol triacetate

amentol triacetate

C33H44O8 (568.3036)


   

Hyperbrasilol A

Hyperbrasilol A

C33H44O8 (568.3036)


   

20-O-Acetyl-12-O-(Z,E)-2,4-octadienoyl-13-O-propionyl-4-desoxyphorbol

20-O-Acetyl-12-O-(Z,E)-2,4-octadienoyl-13-O-propionyl-4-desoxyphorbol

C33H44O8 (568.3036)


   

3-deacetyl salannin

3-deacetyl salannin

C33H44O8 (568.3036)


   

Helvolic acid

NCGC00169132-02_C33H44O8_(4alpha,5alpha,6beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-Diacetoxy-4,8,14-trimethyl-3,7-dioxo-18-norcholesta-1,17,24-trien-21-oic acid

C33H44O8 (568.3036)


A steroid C-21 acid having a 29-nordammarane skeleton substituted with an acetoxy group at C-16 and oxo groups at C-3 and -7, with double bonds at C-1, -17(20) and -24.

   

Lys Lys Met Tyr

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H44N6O6S (568.3043)


   

Lys Lys Tyr Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanoic acid

C26H44N6O6S (568.3043)


   

Lys Met Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H44N6O6S (568.3043)


   

Lys Met Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C26H44N6O6S (568.3043)


   

Lys Tyr Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C26H44N6O6S (568.3043)


   

Lys Tyr Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C26H44N6O6S (568.3043)


   

Met Lys Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C26H44N6O6S (568.3043)


   

Met Lys Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C26H44N6O6S (568.3043)


   

Met Tyr Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanoic acid

C26H44N6O6S (568.3043)


   

Tyr Lys Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C26H44N6O6S (568.3043)


   

Tyr Lys Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C26H44N6O6S (568.3043)


   

Tyr Met Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-(methylsulfanyl)butanamido]hexanamido]hexanoic acid

C26H44N6O6S (568.3043)


   

Ceanothine E

2-(dimethylamino)-N-[7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-3-phenylpropanamide

C34H40N4O4 (568.3049)


   

2-benzofuran-1,3-dione,[2-(hydroxymethyl)-2-methyl-3-(7-methyloctanoyloxy)propyl] 4-tert-butylbenzoate

2-benzofuran-1,3-dione,[2-(hydroxymethyl)-2-methyl-3-(7-methyloctanoyloxy)propyl] 4-tert-butylbenzoate

C33H44O8 (568.3036)


   

3-[18-(2-Carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethyl-21,22,23,24-tetrahydroporphyrin-2-yl]propanoic acid

3-[18-(2-Carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethyl-21,22,23,24-tetrahydroporphyrin-2-yl]propanoic acid

C34H40N4O4 (568.3049)


   

5-Oxoavermectin1b aglycone

5-Oxoavermectin1b aglycone

C33H44O8 (568.3036)


   

protoporphyrinogen

Protoporphyrinogen IX

C34H40N4O4 (568.3049)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

ST 27:6;O2;GlcA

ST 27:6;O2;GlcA

C33H44O8 (568.3036)


   

ST 27:7;O3;Hex

ST 27:7;O3;Hex

C33H44O8 (568.3036)


   

4-{[11,13-dihydroxy-4,4,7,7-tetramethyl-12-(2-methylpropanoyl)-8-oxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]methyl}-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one

4-{[11,13-dihydroxy-4,4,7,7-tetramethyl-12-(2-methylpropanoyl)-8-oxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]methyl}-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one

C33H44O8 (568.3036)


   

(2s)-n-[(3r,4s,7s,10e)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3r,4s,7s,10e)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(2s)-n-[(3r,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3r,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(2s)-n-[(3s,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

(2s)-n-[(3s,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

C34H40N4O4 (568.3049)


   

(1r,2s,4r,6r,9r,10r,11r,12s,14r,15r,18r)-6-(furan-3-yl)-14-hydroxy-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl 2,3-dimethylbut-2-enoate

(1r,2s,4r,6r,9r,10r,11r,12s,14r,15r,18r)-6-(furan-3-yl)-14-hydroxy-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl 2,3-dimethylbut-2-enoate

C33H44O8 (568.3036)


   

6-(furan-3-yl)-14-hydroxy-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl 2,3-dimethylbut-2-enoate

6-(furan-3-yl)-14-hydroxy-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl 2,3-dimethylbut-2-enoate

C33H44O8 (568.3036)


   

n-{7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-2-(dimethylamino)-3-phenylpropanimidic acid

n-{7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

2-[2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-2h,3h,5h,5ah,6h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

2-[2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-2h,3h,5h,5ah,6h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid

C33H44O8 (568.3036)


   

8-[(acetyloxy)methyl]-1-hydroxy-4,12,12,15-tetramethyl-5-oxo-13-(propanoyloxy)tetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl octa-2,4-dienoate

8-[(acetyloxy)methyl]-1-hydroxy-4,12,12,15-tetramethyl-5-oxo-13-(propanoyloxy)tetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl octa-2,4-dienoate

C33H44O8 (568.3036)


   

(2s)-n-[(3r,4r,7r,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

(2s)-n-[(3r,4r,7r,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

C34H40N4O4 (568.3049)


   

(2s)-n-[(7s,10z)-5,8-dihydroxy-3-phenyl-7-(sec-butyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(7s,10z)-5,8-dihydroxy-3-phenyl-7-(sec-butyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

4-({3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4,6-trihydroxy-5-(2-methylpropanoyl)phenyl}methyl)-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one

4-({3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4,6-trihydroxy-5-(2-methylpropanoyl)phenyl}methyl)-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one

C33H44O8 (568.3036)


   

(2s)-n-[(3s,4r,7r,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3s,4r,7r,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

2-{[(2r,6s)-11,13-dihydroxy-4,4,7,7-tetramethyl-12-(2-methylpropanoyl)-8-oxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]methyl}-3,5-dihydroxy-4,4-dimethyl-6-(2-methylpropanoyl)cyclohexa-2,5-dien-1-one

2-{[(2r,6s)-11,13-dihydroxy-4,4,7,7-tetramethyl-12-(2-methylpropanoyl)-8-oxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]methyl}-3,5-dihydroxy-4,4-dimethyl-6-(2-methylpropanoyl)cyclohexa-2,5-dien-1-one

C33H44O8 (568.3036)


   

(2r)-n-[(3r,4r,7s,10e)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2r)-n-[(3r,4r,7s,10e)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

n-{7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-2-(dimethylamino)-4-methylpentanimidic acid

n-{7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-2-(dimethylamino)-4-methylpentanimidic acid

C34H40N4O4 (568.3049)


   

(2r)-n-[(3r,4r,7s,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2r)-n-[(3r,4r,7s,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

2-{[11,13-dihydroxy-4,4,7,7-tetramethyl-12-(2-methylpropanoyl)-8-oxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]methyl}-3,5-dihydroxy-4,4-dimethyl-6-(2-methylpropanoyl)cyclohexa-2,5-dien-1-one

2-{[11,13-dihydroxy-4,4,7,7-tetramethyl-12-(2-methylpropanoyl)-8-oxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]methyl}-3,5-dihydroxy-4,4-dimethyl-6-(2-methylpropanoyl)cyclohexa-2,5-dien-1-one

C33H44O8 (568.3036)


   

(3s)-5-[(1r,2r)-2-[(4e)-6-[2,5-bis(acetyloxy)-3-methylphenyl]-4-methyl-2-oxohex-4-en-1-yl]-1,2-dimethylcyclopentyl]-2-methyl-5-oxopent-1-en-3-yl acetate

(3s)-5-[(1r,2r)-2-[(4e)-6-[2,5-bis(acetyloxy)-3-methylphenyl]-4-methyl-2-oxohex-4-en-1-yl]-1,2-dimethylcyclopentyl]-2-methyl-5-oxopent-1-en-3-yl acetate

C33H44O8 (568.3036)


   

(1s,2r,6s,10r,11s,13s,14s,15s)-8-[(acetyloxy)methyl]-1-hydroxy-4,12,12,15-tetramethyl-5-oxo-13-(propanoyloxy)tetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2z,4e)-octa-2,4-dienoate

(1s,2r,6s,10r,11s,13s,14s,15s)-8-[(acetyloxy)methyl]-1-hydroxy-4,12,12,15-tetramethyl-5-oxo-13-(propanoyloxy)tetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2z,4e)-octa-2,4-dienoate

C33H44O8 (568.3036)


   

2-[(1z,2s,3as,3bs,4s,5as,6s,9ar,9bs,11ar)-2,4-bis(acetyloxy)-3a,3b,6,9a,11a-pentamethyl-5,7-dioxo-2h,3h,4h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-ylidene]-5-methylhex-4-enoic acid

2-[(1z,2s,3as,3bs,4s,5as,6s,9ar,9bs,11ar)-2,4-bis(acetyloxy)-3a,3b,6,9a,11a-pentamethyl-5,7-dioxo-2h,3h,4h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-ylidene]-5-methylhex-4-enoic acid

C33H44O8 (568.3036)


   

(2s)-n-[(3s,4s,7s,10z)-7-[(2r)-butan-2-yl]-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3s,4s,7s,10z)-7-[(2r)-butan-2-yl]-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(2s,3r)-n-[(3s,4r,7r,10e)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylpentanimidic acid

(2s,3r)-n-[(3s,4r,7r,10e)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-methylpentanimidic acid

C34H40N4O4 (568.3049)


   

n-[(10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

n-[(10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

C34H40N4O4 (568.3049)


   

(2s)-n-[(3r,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

(2s)-n-[(3r,4s,7s,10z)-7-benzyl-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid

C34H40N4O4 (568.3049)


   

n-[5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

n-[5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

n-[5,8-dihydroxy-3-phenyl-7-(sec-butyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

n-[5,8-dihydroxy-3-phenyl-7-(sec-butyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(2s)-n-[(3s,4s,7s,10z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3s,4s,7s,10z)-5,8-dihydroxy-7-(2-methylpropyl)-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(3s,6s,9s,12s)-3,6,12-tribenzyl-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

(3s,6s,9s,12s)-3,6,12-tribenzyl-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C34H40N4O4 (568.3049)


   

3,6,12-tribenzyl-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

3,6,12-tribenzyl-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C34H40N4O4 (568.3049)


   

(2s)-n-[(3s,4s,7r,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3s,4s,7r,10z)-7-benzyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(2s)-n-[(3r,4s,7s,10z)-7-[(2s)-butan-2-yl]-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2s)-n-[(3r,4s,7s,10z)-7-[(2s)-butan-2-yl]-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)


   

(2r)-n-[(3r,4r,7s,10e)-7-[(2r)-butan-2-yl]-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

(2r)-n-[(3r,4r,7s,10e)-7-[(2r)-butan-2-yl]-5,8-dihydroxy-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-3-phenylpropanimidic acid

C34H40N4O4 (568.3049)